HIGHLIGHTS
- who: Dilmurodjon Eshmuminov from the Department of Surgery and Transplantation, University Hospital Zurich, University of Zurich, Zurich, Switzerland have published the paper: ASO Author Reflections: Chemotherapy Regimen in Borderline Resectable and Locally Advanced Pancreatic Canceru2014Resection Cuts the Deal, in the Journal: (JOURNAL)
- future: Future prospective studies are necessary to optimize patient selection for each regimen as well as clarify the optimal duration of neoadjuvant treatment.
SUMMARY
ASO AUTHOR REFLECTIONS ASO Author Reflections: Chemotherapy Regimen in Borderline Resectable and Locally Advanced Pancreatic Cancer-Resection Cuts the Deal Dilmurodjon Eshmuminov, MD1, Botirjon Aminjonov . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.